Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Generex Biotechnology Corp. (GNBT)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: GNBT
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Top Authors
Most frequent coverage on GNBT
R.J Steffens
(18 followers)
Oral-lyn vs. Afresa: How Generex Will Beat Mannkind
(Thu, Nov 19)
A N.I.C.E. Development for Generex Oral-lyn in the U.K.
(Sun, Oct 18)
Genentech and Generex: New HER2/neu Research
(Mon, Dec 15)
More by R.J Steffens on GNBT »
VFC's Stock House
(1159 followers)
Four Biotech Stocks to Play the Sector Pullback
(Tue, Nov 3)
Liking the Risk/Reward in Generex
(Mon, Oct 12)
Why I'm Taking a Foothold in Generex Now
(Mon, Oct 12)
More by VFC's Stock House on GNBT »
ChinaBio Today
(347 followers)
Biotech in Review: Positive Consolidation in China Life Science Companies
(Mon, Apr 21)
China Biotech Week in Review: Anesiva Forms JV with Fosun Pharma
(Sun, Oct 14)
Generex To Test Cancer Vaccine in China
(Wed, Oct 10)
More by ChinaBio Today on GNBT »
Most followed authors on GNBT
VFC's Stock House
(1159 followers)
Four Biotech Stocks to Play the Sector Pullback
(Tue, Nov 3)
Liking the Risk/Reward in Generex
(Mon, Oct 12)
Why I'm Taking a Foothold in Generex Now
(Mon, Oct 12)
More by VFC's Stock House on GNBT »
Babak
(565 followers)
Swine Flu Stock Watchlist
(Thu, Apr 30)
More by Babak on GNBT »
M. E. Garza
(540 followers)
Increased Interest in Cel-Sci After Latest SEC Filing
(Wed, Aug 26)
More by M. E. Garza on GNBT »
Newest authors on GNBT
M. E. Garza
(540 followers)
Increased Interest in Cel-Sci After Latest SEC Filing
(Wed, Aug 26)
More by M. E. Garza on GNBT »
Thomas Barnard
(9 followers)
Big Pharma: Where's the Risk Management?
(Tue, Jul 7)
More by Thomas Barnard on GNBT »
VFC's Stock House
(1159 followers)
Four Biotech Stocks to Play the Sector Pullback
(Tue, Nov 3)
Liking the Risk/Reward in Generex
(Mon, Oct 12)
Why I'm Taking a Foothold in Generex Now
(Mon, Oct 12)
More by VFC's Stock House on GNBT »
Most commented on GNBT
R.J Steffens
(18 followers)
Oral-lyn vs. Afresa: How Generex Will Beat Mannkind
(Thu, Nov 19)
A N.I.C.E. Development for Generex Oral-lyn in the U.K.
(Sun, Oct 18)
Genentech and Generex: New HER2/neu Research
(Mon, Dec 15)
More by R.J Steffens on GNBT »
VFC's Stock House
(1159 followers)
Four Biotech Stocks to Play the Sector Pullback
(Tue, Nov 3)
Liking the Risk/Reward in Generex
(Mon, Oct 12)
Why I'm Taking a Foothold in Generex Now
(Mon, Oct 12)
More by VFC's Stock House on GNBT »
Thomas Barnard
(9 followers)
Big Pharma: Where's the Risk Management?
(Tue, Jul 7)
More by Thomas Barnard on GNBT »